In vivo studies are needed to determine whether carnosic acid inhibits the EMT, thereby inhibiting melanoma metastasis in animal tumor models and whether inhibition of the Src/FAK pathway directly contributes to inhibit the EMT. This evidence concerns the gene PTK2 and melanoma.